Search Results - "Xiao, Taiwu"
-
1
Efficacy of Surgery Combined with Autologous Bone Marrow Stromal Cell Transplantation for Treatment of Intracerebral Hemorrhage
Published in Stem Cells International (01-01-2015)“…Bone marrow stromal cells (BMSCs) may differentiate into nerve cells under a certain condition; however, the clinical application for treating nervous system…”
Get full text
Journal Article -
2
Abnormal GRHL2 Methylation Confers Malignant Progression to Acute Leukemia
Published in Applied bionics and biomechanics (2022)“…Purpose. Abnormal methylation of Grainyhead-like 2 (GRHL2) is associated with a substantial role in the malignant phenotype of tumor patients. Our present…”
Get full text
Journal Article -
3
C-X-C Chemokine Receptor 4 in Diffuse Large B Cell Lymphoma: Achievements and Challenges
Published in Acta haematologica (01-01-2019)“…Diffuse large B cell lymphoma (DLBCL), an aggressive cancer of the B cells, is the most common subtype of non-Hodgkin lymphoma (NHL) worldwide. In China, the…”
Get more information
Journal Article -
4
Human serum albumin promotes self-renewal and expansion of umbilical cord blood CD34 + hematopoietic stem/progenitor cells
Published in Annals of translational medicine (31-01-2023)“…We investigated the effect of human serum albumin (HSA) on human umbilical cord blood (UCB) CD34 hematopoietic stem/progenitor cells (HSPCs) cultured and…”
Get full text
Journal Article -
5
Efficacy and safety of generic pomalidomide plus low-dose dexamethasone in relapsed or refractory multiple myeloma: a multicenter, open-label, single-arm trial
Published in Annals of hematology (01-03-2024)“…This multicenter, open-label, single-arm trial (ClinicalTrials.gov, NCT05236621) was conducted to confirm the efficacy and safety of generic pomalidomide plus…”
Get full text
Journal Article -
6
Tim-3 expression is increased on peripheral T cells from diffuse large B cell lymphoma
Published in Tumor biology (01-08-2014)“…T cell immunoglobulin- and mucin-domain-containing molecule 3 (Tim-3) plays a critical role in immune tolerance by suppressing the activation and proliferation…”
Get full text
Journal Article -
7
Efficacy and safety of sovleplenib (HMPL-523) in adult patients with chronic primary immune thrombocytopenia in China (ESLIM-01): a randomised, double-blind, placebo-controlled, phase 3 study
Published in The Lancet. Haematology (01-08-2024)“…Sovleplenib, a novel spleen tyrosine kinase (SYK) inhibitor, showed promising safety and activity in patients with primary immune thrombocytopenia in a phase…”
Get full text
Journal Article -
8
Fibroblast growth factor receptor 4 polymorphism is associated with increased risk and poor prognosis of non-Hodgkin’s lymphoma
Published in Tumor biology (01-04-2014)“…Fibroblast growth factor receptor 4 (FGFR4) is expressed in various cell types and plays important roles in regulating immune responses. Evidence has shown…”
Get full text
Journal Article -
9
shRNA-mediated RPS15A silencing inhibits U937 acute myeloid leukemia cell proliferation and enhances apoptosis
Published in Molecular medicine reports (01-05-2016)“…Ribosomal protein S15a (RPS15A), which is a component of the 40S ribosomal subunit, is able to promote mRNA/ribosome interaction during the early stage of…”
Get full text
Journal Article